TetraLogic Reports Initiation of Randomized Phase 2 Trial of SHAPE for Cutaneous T-Cell Lymphoma
December 18, 2014 at 07:21 AM EST
TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG) today announced the initiation of a randomized Phase 2 clinical trial of SHAPE ...